Avondale Partners Downgrades TrueBlue (TBI) to Underperform
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $10.09 +1.92%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 42 | New: 4
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 21 | Down: 42 | New: 4
Join SI Premium – FREE
Avondale Partners downgraded TrueBlue (NYSE: TBI) from Market Outperform to Underperform with a price target of $15.00 (from $20.00).
For an analyst ratings summary and ratings history on TrueBlue click here. For more ratings news on TrueBlue click here.
Shares of TrueBlue closed at $20.00 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Establishment Labs Inc. (ESTA) PT Raised to $105 at Canaccord
- Haemonetics (HAE) PT Raised to $96 at BTIG
- Freedom Broker Downgrades Zeta Global Holdings Corp (ZETA) to Hold
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
Avondale PartnersSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
